Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cavan Reilly, PhD
University of Minnesota
Principal Investigator - Jason Baker, MD
University of Minnesota
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
187 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Medico Platense (site 611-025)
La Plata, Buenos Aires, Argentina
- Sanatorio Allende (site 611-030)
Córdoba, Córdoba Province, Argentina
- Clínica Central S.A. (611-028)
Villa Regina, Río Negro Province, Argentina
- Sanatorio Británico S.A. (611-027)
Rosario, Santa Fe Province, Argentina
- Cemic (site 611-021)
Buenos Aires, Argentina
- Hospital Rawson (site 611-012)
Córdoba, Argentina
- Sanatorio Medico de Diagnostico Y Tratamiento (611-029)
Santa Fe, Argentina
- South Western Sydney Local Health District, Liverpool (site 612-063)
Liverpool, New South Wales, Australia
- St. Vincent'S Hospital (site 612-002)
Sydney, New South Wales, Australia
- Westmead Hospital (site 612-058)
Westmead, New South Wales, Australia
- Austin Health (612-020)
Heidelberg, Victoria, Australia
- the Alfred Hospital (site 612-017)
Melbourne, Victoria, Australia
- Fundação Universidade Caxias Do Sul Hospital Geral (649-218)
Caxias do Sul, Rio Grande do Sul, Brazil
- Hospital de Clínicas de Porto Alegre (649-101)
Porto Alegre, Rio Grande do Sul, Brazil
- Sociedade Literária E Caritativa Santo Agostinho - Hospital São José (site 649-204)
Criciúma, Santa Catarina, Brazil
- Hospital Nereu Ramos (site 649-210)
Florianópolis, Santa Catarina, Brazil
- Unimed Joinville Cooperativa de Trabalho Médico (site 649-202)
Joinville, Santa Catarina, Brazil
- Associação Beneficente Hospital Universitário - Universidade de Marília (site 649-212)
Marília, São Paulo, Brazil
- Associação Beneficente Síria - Hcor (site 649-203)
São Paulo, São Paulo, Brazil
- Hospital Alemão Oswaldo Cruz (649-215)
São Paulo, São Paulo, Brazil
- Hospital Sepaco (649-207)
São Paulo, São Paulo, Brazil
- Instituto de Infectologia Emílio Ribas - Iier (site 649-001)
São Paulo, São Paulo, Brazil
- Real E Benemérita Associação Portuguesa de Beneficência de São Paulo (site 649-201
São Paulo, São Paulo, Brazil
- Sociedade Beneficente de Senhoras Hospital Sirio-Libanês (site 649-217)
São Paulo, São Paulo, Brazil
- Aarhus Universitetshospital, Skejby (625-002)
Aarhus, N, Denmark
- Aalborg Hospital (site 625-005)
Aalborg, Denmark
- Bispebjerg Hospital (site 625-013)
Copenhagen, Denmark
- Rigshospitalet, Chip (site 625-006)
Copenhagen, Denmark
- Herlev/gentofte Hospital (site 625-012)
Hellerup, Denmark
- Nordsjaellands Hospital, Hillerod (site 625-009)
Hillerød, Denmark
- Hvidovre University Hospital, Department of Infections Diseases (site 625-001)
Hvidovre, Denmark
- Kolding Sygehus, Medicinsk Afdeling (site 625-011)
Kolding, Denmark
- Odense University Hospital (site 625-004)
Odense, Denmark
- Zealand University Hospital Roskilde (site 625-010)
Roskilde, Denmark
- Aids and Clinical Immunology Research Center (site 627-201)
Tbilisi, Georgia
- Universitätsklinikum Bonn, Medizinische Klinik I, Immunologische Ambulanz (622-010)
Bonn, Germany
- Klinik I Für Innere Medizin Der Universität Zu Köln (site 622-008)
Cologne, Germany
- Johann Wolfgang Goethe Univ. Hosp., Infektionsambulanz Crs (622-001)
Frankfurt, Germany
- 1st Respiratory Medicine Dept, Athens University Medical School (635-015)
Athens, Attica, Greece
- 3rd Dept of Medicine, Medical School (635-022)
Athens, Attica, Greece
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Dec 2022
- Primary completion
- 28 Oct 2025
- Completion
- 28 Oct 2025
- Last update posted
- 17 Nov 2025
- Registered enrollment
- 602
- Registry id
- NCT05605093
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.